Dynavax Technologies Corporation DSO Ratio 2011-2025 | DVAX

Annual DSO Ratio Dynavax Technologies Corporation

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
56.5	146	66	57.7	124	92.1	165	953	44.4	126	24.1	52.8	37.8	161

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
953	24.1	150

Quarterly DSO Ratio Dynavax Technologies Corporation

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
68.8	60	67.1	-	76.4	65.4	76.2	-	58.8	110	240	-	-	-	-	-	129	164	58.4	-	196	775	132	76.7	76.7	97.7	99.5	63.6	231	270	1.26 K	3.71 K	1.47 K	742	677	16.8	756	43.2	124	170	69.9	46.1	119	29.1	30	21.8	30.7	52.1	50.7	43.8	57.6	50.8	31.9	34.2	204	76.1	740	120	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
3.71 K	16.8	279

DSO Ratio of other stocks in the Biotechnology industry

Issuer	DSO Ratio	Price	% 24h	Market Cap	Country
AbbVie ABBV	267	$ 223.98	-0.53 %	$ 396 B	USA
Alpine Immune Sciences ALPN	154	-	-	$ 2.17 B	USA
Arbutus Biopharma Corporation ABUS	31.5	$ 4.67	1.74 %	$ 775 M	Canada
Aclaris Therapeutics ACRS	6.01	$ 3.36	2.75 %	$ 260 M	USA
Acasti Pharma ACST	1.97	-	4.01 %	$ 150 M	Canada
Adaptimmune Therapeutics plc ADAP	25	-	-15.15 %	$ 60.3 M	Britain
Aeglea BioTherapeutics AGLE	216	-	-	$ 1.01 B	USA
Alexion Pharmaceuticals, Inc. ALXN	84.7	-	-	$ 40.3 B	USA
Albireo Pharma ALBO	14.7	-	-0.23 %	$ 916 M	USA
Ascendis Pharma A/S ASND	132	$ 210.16	4.43 %	$ 5 B	Danmark
Ayala Pharmaceuticals AYLA	61.7	-	-	$ 7.46 M	Israel
Aptorum Group Limited APM	20.6	$ 1.33	-1.48 %	$ 7.25 M	China
Alterity Therapeutics Limited ATHE	16.2 K	$ 3.42	2.09 %	$ 8.23 B	Australia
EyeGate Pharmaceuticals, Inc. EYEG	2.75 K	-	-1.52 %	$ 24.7 M	USA
Amphastar Pharmaceuticals AMPH	62.6	$ 25.9	0.74 %	$ 1.25 B	USA
Anika Therapeutics ANIK	77.3	$ 9.49	-	$ 139 M	USA
Brickell Biotech BBI	254	-	-5.38 %	$ 6.06 M	USA
BeiGene, Ltd. BGNE	49.5	-	0.49 %	$ 251 B	Cayman-islands
Bellicum Pharmaceuticals BLCM	6.09	-	-9.72 %	$ 5.89 M	USA
Berkeley Lights BLI	103	-	-7.31 %	$ 87 M	USA
Aytu BioScience AYTU	150	$ 2.28	-	$ 14.3 M	USA
Arena Pharmaceuticals ARNA	946	-	-6.81 %	$ 3.04 B	USA
Biogen BIIB	57.9	$ 172.5	-	$ 25.1 B	USA
Baudax Bio BXRX	126	-	0.59 %	$ 63 K	USA
Benitec Biopharma BNTC	141	$ 12.96	1.17 %	$ 533 M	USA
ChromaDex Corporation CDXC	13.2	-	-0.88 %	$ 598 M	USA
Axon Enterprise AXON	134	$ 581.03	2.22 %	$ 44 B	USA
Can-Fite BioPharma Ltd. CANF	28.1	$ 0.29	-0.31 %	$ 631 M	Israel
Checkpoint Therapeutics CKPT	6.83	-	-	$ 169 M	USA
Caladrius Biosciences CLBS	164	-	-16.75 %	$ 25.8 M	USA
Catalyst Biosciences CBIO	3.24	$ 15.31	-	$ 1.01 B	USA
Clovis Oncology CLVS	65.5	-	-7.23 %	$ 13 M	USA
Cerus Corporation CERS	59.2	$ 2.15	13.76 %	$ 397 M	USA
Celldex Therapeutics CLDX	86.5	$ 27.94	-	$ 1.8 M	USA
Deciphera Pharmaceuticals DCPH	60.8	-	-	$ 2.18 B	USA
Biohaven Pharmaceutical Holding Company Ltd. BHVN	169	$ 11.44	7.92 %	$ 740 M	USA
Eloxx Pharmaceuticals ELOX	157	-	-5.68 %	$ 8.28 M	USA
Epizyme EPZM	47.2	-	-	$ 249 M	USA